Found 7 matching trials
Neoadjuvant Toripalimab in Combination with Gemcitabine and Cisplatin Therapy in Local Advanced Bladder Cancer Subjects
PHASE2This is a pre-surgical study involving subjects with local advanced bladder...
Location
Zhujiang Hospital
Toripalimab Plus Lenvatinib and Gemcitabine-based Chemotherapy in 1L Treatment of Advanced ICC: a Phase III Study
PHASE3This is a Phase III, prospective, randomized, three-arm, double-blind, plac...
Location
Zhongshan Hospital affiliated to Fudan University
EV + Toripalimab vs GC as Neoadjuvant Therapy in Locally Advanced/High-Risk MIBC
PHASE2The purpose of this Phase II, open-label, multicenter, randomized controlle...
Location
Peking University Third Hospital
Remodeling of MHC-related Immune Microenvironment in MIBC After Neoadjuvant Therapy
N/AIn this study, the relevant biomarkers for predicting the efficacy of neoad...
Location
Multiple Locations
Neoadjuvant Treatment of Upper Urinary and Muscular Invasive Bladder Urothelial Carcinoma
PHASE2Few previous studies focused on the neoadjuvant treatments of upper urinary...
Location
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
HOPE-07-MIBC: Disitamab Vedotin Plus Immunotherapy vs Chemoimmunotherapy in Resectable HER2-Expressing MIBC
PHASE2This is a multicenter, randomized controlled clinical trial (HOPE-07) desig...
Location
Multiple Locations
Toripalimab With or Without Lenvatinib or Chemotherapy in First-Line Treatment of Advanced Biliary Tract Cancer
PHASE2Explore the impact of the first-line application of Toripalimab with or wit...
Location
Chinese Academy of Medical Sciences & Peking Union Medical College Hospital (CAMS&PUMCH)